Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
OA02 - From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Treatment
- 12:00 - 13:00
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Moderators:Isabelle Opitz, Luis Paz-Ares
-
+
Session Moderator
12:00 - 12:00 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Isabelle Opitz
- Abstract
Loading... -
+
OA02.01 - Session Introduction
12:00 - 12:01 | Presenter: Isabelle Opitz
- Abstract
Loading... -
+
OA02.02 - Session Introduction
12:01 - 12:02 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
OA02.03 - Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial
12:02 - 12:12 | Presenter: Marta Casarrubios
- Abstract
Loading... -
+
OA02.04 - Multimodal Management of T4 N2 Non-small-cell Lung Cancer with Additional Ipsilateral Pulmonary Nodules
12:12 - 12:22 | Presenter: Arvind Kumar
- Abstract
Loading... -
+
OA02.05 - Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study
12:22 - 12:32 | Presenter: Yi-Long Wu
- Abstract
Loading... -
+
OA02.06 - Discussant
12:32 - 12:42 | Presenter: Linda Martin
- Abstract
Loading... -
+
OA02.07 - Live Q&A
12:42 - 13:00
- Abstract
Loading...
-
+
IS11 - Industry Symposium Sponsored by Amgen Inc.: Driving Advancements in the Treatment of Lung Cancer
- 13:15 - 14:15
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Industry Symposium
- Track: N/A
-
+
Session Moderator
13:15 - 13:15 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
IS11.01 - Welcome and Introduction to Innovative Treatments for New Targets in Lung Cancer
13:15 - 13:30 | Presenter: Luis Paz-Ares
- Abstract
Loading...
-
+
OA03 - Molecular Targeted Treatments
- 14:30 - 15:40
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Andrew Ciupek, David R. Gandara
-
+
OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
14:42 - 14:52 | Presenter: Adrian Sacher
- Abstract
Loading...
-
+
MA05 - Immune Landscape and Molecular Profiling of Lung Cancer
- 15:45 - 16:45
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Luis Paz-Ares, Tina Cascone
-
+
Session Moderator
15:45 - 15:45 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:45 | Presenter: Tina Cascone
- Abstract
Loading... -
+
MA05.01 - Session Introduction
15:45 - 15:46 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
MA05.02 - Session Introduction
15:46 - 15:47 | Presenter: Tina Cascone
- Abstract
Loading... -
+
MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer
15:47 - 15:52 | Presenter: Wenbin Li
- Abstract
Loading... -
+
MA05.04 - Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC
15:52 - 15:57 | Presenter: Max Wilhelm Backman
- Abstract
Loading... -
+
MA05.05 - Analysis of CREBBP as a Potential Biomarker for Immune Checkpoint Therapy in Solid Tumors and Its Correlation With Immune Microenvironment
15:57 - 16:02 | Presenter: Xiaoli Liu
- Abstract
Loading... -
+
MA05.06 - Discussant
16:02 - 16:12 | Presenter: Fabio Pagni
- Abstract
Loading... -
+
MA05.07 - Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer With MET Exon 14 Skipping
15:57 - 16:02 | Presenter: Yuchen Han
- Abstract
Loading... -
+
MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
16:17 - 16:22 | Presenter: Jennifer A. Marks
- Abstract
Loading... -
+
MA05.09 - Genomic Mapping of Metastatic Organotropism: Analysis of 2326 Primary and Organ-Specific Metastases in Lung Adenocarcinoma
16:22 - 16:27 | Presenter: Harry Lengel
- Abstract
Loading... -
+
MA05.10 - Discussant
16:27 - 16:37 | Presenter: Giulia Pasello
- Abstract
Loading... -
+
MA05.11 - Live Q&A
16:37 - 16:45
- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-029 - NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
Presenter: Ernest Nadal- Abstract
Loading...
-
+
EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
-
+
EP14.01-015 - IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC
Presenter: Luis Paz-Ares- Abstract
Loading... -
+
EP14.01-020 - Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer
Presenter: Stephen V. Liu- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
-
+
EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity
Presenter: Francesco Passiglia- Abstract
Loading...
-
+
P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
P1.16-04 - Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors
Presenter: Niels Reinmuth- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Alessandra Curioni-Fontecedro, Kostas Syrigos
-
+
OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer
16:22 - 16:32 | Presenter: Hossein Borghaei
- Abstract
Loading...
-
+
P2.07 - Pathology - Tumour Genomics
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Pathology - Tumour Genomics
-
+
P2.07-02 - RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
Presenter: Susana Hernandez- Abstract
Loading...
